A PEGylated 96-well polystyrene (PS) microplate was first introduced for applications in high-throughput screening for selective blood typing to minimize the risks in blood transfusions. Herein, we ...

Acquisition and Mergers: Oct-2018: Stryker acquired HyperBranch Medical Technology in order to develop medical devices for various implants.

Arrinex’s ClariFix device gave Stryker the opportunity to address a “large, underpenetrated segment of the ENT market,” the company said. HyperBranch Medical Technology. Stryker paid $220 million for ...

HyperBranch is dedicated to developing medical devices based on its proprietary polymers and cross-linked hydrogels. Its Adherus AutoSpray Dural Sealant product is one of only two FDA-approved dural ...

H.I.G. BioHealth Partners, the healthcare investment affiliate of H.I.G. Capital, said Oct. 11 that closed the sale of it HyperBranch Medical Technology Inc to Stryker Corp for about $220 million ...

Stryker has acquired HyperBranch Medical Technology for $220m in cash. Based in the US, Stryker is a medical technology company, while HyperBranch, also based in the US, is a medical device developer.